Skip to main content
OpenTrials
Completed

NCT Number: NCT02006004

Epidemiologic Registry PETHEMA LMA 2013

Epidemiologic and retrospective multicenter registry of all patients diagnosed with de novo or secondary AML in the PETHEMA Group institutions. This study is a non-interventional research regarding diagnosis and therapeutic approach

Completed

Looking for future studies?

Notify Me

Key information

Conditions

AML

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital La Fe

Valencia, Spain

About this study

To perform this registry, every patient diagnosed with AML in the participant institutions, regardless type of AML and treatment administered, must be reported. It will be required to registry the main characteristics of the patients and AML at diagnosis, as cytomorphologic, immunophenotypic, and cytogenetic results, according to the habitual practice of the centers. The treatment which has been administered by every center of the PETHEMA Group, even when it is considered as supportive care, and evolution of the disease will also be reported (relapse o death). PETHEMA Group will input all the reported information in data bases with the appropriate security.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients diagnosed with acute myeloid leukemia

Exclusion criteria

no exclusion criteria

Treatment and study plan

Primary outcomes

  1. Characteristics of the patients diagnosed with AML

    Time frame: 3 years

    To realize an epidemiologic and retrospective study to assess the characteristics of the patients diagnosed with AML and their disease, regardless the age or treatment

Secondary outcomes

  1. Prognosis factors

    Time frame: 3 years

    To correlate clinical and biological features with outcome and evolution of the patients.

  2. Risk factors

    Time frame: 3 years

    To identify and confirm the risk factors which are involved in the evolution of the disease.

Sponsors and collaborators

Lead sponsor

PETHEMA Foundation

Other

Registry information

Official study title

Epidemiologic Registry of Patients Diagnosed With Acute Myeloid Leukemia (PETHEMA LMA 2013)

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Dec 9, 2013
Registry last updated
Oct 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.